methylene blue has been researched along with sertraline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deianova, N; Hemelsoet, D; Honoré, PJ; Loret, G | 1 |
1 other study(ies) available for methylene blue and sertraline
| Article | Year |
|---|---|
An easily overlooked cause of toxic encephalopathy: methylene blue in a patient on an SSRI.
Topics: Aged; Humans; Male; Methylene Blue; Monoamine Oxidase Inhibitors; Neurotoxicity Syndromes; Parathyroidectomy; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2018 |